Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: March 22, 2023

Patent: 10,004,788

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 10,004,788
Title:Treatment of ocular neovascularization using anti-VEGF proteins
Abstract: The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
Inventor(s): Constable; Ian J. (Mosman Park, AU), Rakoczy; P. Elizabeth (Scarborough, AU), Lai; Chooi-May (Waterford, AU), Chalberg, Jr.; Thomas W. (Redwood City, CA)
Assignee: Avalanche Australia Pty Ltd. (Southbank, AU)
Application Number:15/851,650
Patent Claims:see list of patent claims

Details for Patent 10,004,788

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 06/30/2006 See Plans and Pricing 2032-05-15
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 08/10/2012 See Plans and Pricing 2032-05-15
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 10/13/2016 See Plans and Pricing 2032-05-15
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.